170 related articles for article (PubMed ID: 31401653)
1. Folic acid supplementation and risk of colorectal neoplasia during long-term follow-up of a randomized clinical trial.
Passarelli MN; Barry EL; Rees JR; Mott LA; Zhang D; Ahnen DJ; Bresalier RS; Haile RW; McKeown-Eyssen G; Snover DC; Cole BF; Baron JA
Am J Clin Nutr; 2019 Oct; 110(4):903-911. PubMed ID: 31401653
[TBL] [Abstract][Full Text] [Related]
2. Folic acid for the prevention of colorectal adenomas: a randomized clinical trial.
Cole BF; Baron JA; Sandler RS; Haile RW; Ahnen DJ; Bresalier RS; McKeown-Eyssen G; Summers RW; Rothstein RI; Burke CA; Snover DC; Church TR; Allen JI; Robertson DJ; Beck GJ; Bond JH; Byers T; Mandel JS; Mott LA; Pearson LH; Barry EL; Rees JR; Marcon N; Saibil F; Ueland PM; Greenberg ER;
JAMA; 2007 Jun; 297(21):2351-9. PubMed ID: 17551129
[TBL] [Abstract][Full Text] [Related]
3. A randomized trial on folic acid supplementation and risk of recurrent colorectal adenoma.
Wu K; Platz EA; Willett WC; Fuchs CS; Selhub J; Rosner BA; Hunter DJ; Giovannucci E
Am J Clin Nutr; 2009 Dec; 90(6):1623-31. PubMed ID: 19864409
[TBL] [Abstract][Full Text] [Related]
4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
5. Chemoprevention of colorectal cancer: systematic review and economic evaluation.
Cooper K; Squires H; Carroll C; Papaioannou D; Booth A; Logan RF; Maguire C; Hind D; Tappenden P
Health Technol Assess; 2010 Jun; 14(32):1-206. PubMed ID: 20594533
[TBL] [Abstract][Full Text] [Related]
6. Folic acid supplementation inhibits recurrence of colorectal adenomas: a randomized chemoprevention trial.
Jaszewski R; Misra S; Tobi M; Ullah N; Naumoff JA; Kucuk O; Levi E; Axelrod BN; Patel BB; Majumdar AP
World J Gastroenterol; 2008 Jul; 14(28):4492-8. PubMed ID: 18680228
[TBL] [Abstract][Full Text] [Related]
7. The association between colorectal sessile serrated adenomas/polyps and subsequent advanced colorectal neoplasia.
Burnett-Hartman AN; Chubak J; Hua X; Ziebell R; Kamineni A; Zhu LC; Upton MP; Malen RC; Hardikar S; Newcomb PA
Cancer Causes Control; 2019 Sep; 30(9):979-987. PubMed ID: 31290073
[TBL] [Abstract][Full Text] [Related]
8. Effect of Supplementation With Marine ω-3 Fatty Acid on Risk of Colorectal Adenomas and Serrated Polyps in the US General Population: A Prespecified Ancillary Study of a Randomized Clinical Trial.
Song M; Lee IM; Manson JE; Buring JE; Dushkes R; Gordon D; Walter J; Wu K; Chan AT; Ogino S; Fuchs CS; Meyerhardt JA; Giovannucci EL;
JAMA Oncol; 2020 Jan; 6(1):108-115. PubMed ID: 31750855
[TBL] [Abstract][Full Text] [Related]
9. No Association Between Vitamin D Supplementation and Risk of Colorectal Adenomas or Serrated Polyps in a Randomized Trial.
Song M; Lee IM; Manson JE; Buring JE; Dushkes R; Gordon D; Walter J; Wu K; Chan AT; Ogino S; Fuchs CS; Meyerhardt JA; Giovannucci EL
Clin Gastroenterol Hepatol; 2021 Jan; 19(1):128-135.e6. PubMed ID: 32062040
[TBL] [Abstract][Full Text] [Related]
10. Antagonistic effects of aspirin and folic acid on inflammation markers and subsequent risk of recurrent colorectal adenomas.
Ho GY; Xue X; Cushman M; McKeown-Eyssen G; Sandler RS; Ahnen DJ; Barry EL; Saibil F; Bresalier RS; Rohan TE; Baron JA
J Natl Cancer Inst; 2009 Dec; 101(23):1650-4. PubMed ID: 19822838
[TBL] [Abstract][Full Text] [Related]
11. Folic acid and risk of prostate cancer: results from a randomized clinical trial.
Figueiredo JC; Grau MV; Haile RW; Sandler RS; Summers RW; Bresalier RS; Burke CA; McKeown-Eyssen GE; Baron JA
J Natl Cancer Inst; 2009 Mar; 101(6):432-5. PubMed ID: 19276452
[TBL] [Abstract][Full Text] [Related]
12. Colorectal adenomas in a randomized folate trial: the role of baseline dietary and circulating folate levels.
Figueiredo JC; Levine AJ; Grau MV; Barry EL; Ueland PM; Ahnen DJ; Byers T; Bresalier RS; Summers RW; Bond J; McKeown-Eyssen GE; Sandler RS; Haile RW; Baron JA
Cancer Epidemiol Biomarkers Prev; 2008 Oct; 17(10):2625-31. PubMed ID: 18843003
[TBL] [Abstract][Full Text] [Related]
13. Folic acid prevents the initial occurrence of sporadic colorectal adenoma in Chinese older than 50 years of age: a randomized clinical trial.
Gao QY; Chen HM; Chen YX; Wang YC; Wang ZH; Tang JT; Ge ZZ; Chen XY; Sheng JQ; Fang DC; Yu CG; Zheng P; Fang JY
Cancer Prev Res (Phila); 2013 Jul; 6(7):744-52. PubMed ID: 23682073
[TBL] [Abstract][Full Text] [Related]
14. Uracil misincorporation into DNA and folic acid supplementation.
Hazra A; Selhub J; Chao WH; Ueland PM; Hunter DJ; Baron JA
Am J Clin Nutr; 2010 Jan; 91(1):160-5. PubMed ID: 19923375
[TBL] [Abstract][Full Text] [Related]
15. Eicosapentaenoic acid and aspirin, alone and in combination, for the prevention of colorectal adenomas (seAFOod Polyp Prevention trial): a multicentre, randomised, double-blind, placebo-controlled, 2 × 2 factorial trial.
Hull MA; Sprange K; Hepburn T; Tan W; Shafayat A; Rees CJ; Clifford G; Logan RF; Loadman PM; Williams EA; Whitham D; Montgomery AA;
Lancet; 2018 Dec; 392(10164):2583-2594. PubMed ID: 30466866
[TBL] [Abstract][Full Text] [Related]
16. Long-term Risk of Colorectal Cancer After Removal of Conventional Adenomas and Serrated Polyps.
He X; Hang D; Wu K; Nayor J; Drew DA; Giovannucci EL; Ogino S; Chan AT; Song M
Gastroenterology; 2020 Mar; 158(4):852-861.e4. PubMed ID: 31302144
[TBL] [Abstract][Full Text] [Related]
17. Nonsteroidal anti-inflammatory drug use after 3 years of aspirin use and colorectal adenoma risk: observational follow-up of a randomized study.
Grau MV; Sandler RS; McKeown-Eyssen G; Bresalier RS; Haile RW; Barry EL; Ahnen DJ; Gui J; Summers RW; Baron JA
J Natl Cancer Inst; 2009 Feb; 101(4):267-76. PubMed ID: 19211442
[TBL] [Abstract][Full Text] [Related]
18. Vitamins B2, B6, and B12 and risk of new colorectal adenomas in a randomized trial of aspirin use and folic acid supplementation.
Figueiredo JC; Levine AJ; Grau MV; Midttun O; Ueland PM; Ahnen DJ; Barry EL; Tsang S; Munroe D; Ali I; Haile RW; Sandler RS; Baron JA
Cancer Epidemiol Biomarkers Prev; 2008 Aug; 17(8):2136-45. PubMed ID: 18708408
[TBL] [Abstract][Full Text] [Related]
19. Body Composition and Aspirin Dose for Colorectal Adenoma Prevention in a Randomized Clinical Trial.
Passarelli MN; Barry EL; Rees JR; Mott LA; Ahnen DJ; Baron JA
Cancer Epidemiol Biomarkers Prev; 2019 Jul; 28(7):1262-1265. PubMed ID: 31263057
[TBL] [Abstract][Full Text] [Related]
20. Factors Associated With Shorter Colonoscopy Surveillance Intervals for Patients With Low-Risk Colorectal Adenomas and Effects on Outcome.
Anderson JC; Baron JA; Ahnen DJ; Barry EL; Bostick RM; Burke CA; Bresalier RS; Church TR; Cole BF; Cruz-Correa M; Kim AS; Mott LA; Sandler RS; Robertson DJ
Gastroenterology; 2017 Jun; 152(8):1933-1943.e5. PubMed ID: 28219690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
